For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Standard Care + Financial Incentives | Participants randomized to Standard Care + Financial Incentives for Abstinence will be offered smoking cessation counseling and pharmacotherapy (standard care) and they will have the opportunity to earn small gift cards for biochemically-verified abstinence through 12 weeks post-quit. The amount of the gift cards will escalate each week from the quit date through 4 weeks post-quit with continuous abstinence. Participants who are non-abstinent at any visit may earn incentives for abstinence at the next visit, but the amount will reset to the starting level. Participants may additionally earn an additional gift card for abstinence at the 8 and 12 weeks post-quit visits. Standard Care + Financial Incentives: Tobacco cessation counseling plus pharmacotherapy and financial incentives for quitting. | 0 | None | 0 | 159 | 2 | 159 | View |
| Standard Care | Participants randomized to Standard Care will be offered weekly smoking cessation counseling and pharmacotherapy. Standard Care: Tobacco cessation counseling plus pharmacotherapy. | 0 | None | 0 | 161 | 2 | 161 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Blood in Urine | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Fatigue | NON_SYSTEMATIC_ASSESSMENT | Product Issues | None | View |
| Dissatisfaction with compensation | NON_SYSTEMATIC_ASSESSMENT | Social circumstances | None | View |
| Study smartphone was stolen | NON_SYSTEMATIC_ASSESSMENT | Social circumstances | None | View |